Clinical Efficacy of Xiaochaihu Decoction Combined with Guizhi Fuling Pill in Adjuvant Treatment of AECOPD and Its Influence on Inflammatory Factors in Patients

Authors

  • Zhen Liu Shenzhen Bao'an District Hospital of Traditional Chinese Medicine, 518133, Shenzhen, Guangdong, China Author
  • Zhiyong Peng Shenzhen Bao'an District Traditional Chinese Medicine Hospital, 518101, Guangdong, China. Author
  • Ping Zheng Shenzhen Bao'an District Hospital of Traditional Chinese Medicine, 518133, Shenzhen, Guangdong, China Author
  • Liandeng Xu Shenzhen Bao'an District Hospital of Traditional Chinese Medicine, 518133, Shenzhen, Guangdong, China Author

Keywords:

Xiaochaihu Decoction combined with Guizhi Fuling Pill, Acute exacerbation of chronic obstructive pulmonary disease, Inflammatory factors, Pulmonary function

Abstract

Background: We analyzed the clinical efficacy of Xiaochaihu Decoction combined with Guizhi Fuling Pill in adjuvant treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods: 108 patients with AECOPD were randomly divided into control group and observation group. Patients in control group were treated with conventional therapy, while patients in observation group were treated with Xiaochaihu Decoction and Guizhi Fuling Pill on the basis of the control group. Clinical symptoms, pulmonary function, scores of modified British Medical Research Council Respiratory Questionnaire (mMRC), self-assessment test questionnaire (CAT), and the levels of inflammatory factors were compared between the two groups. Results: After treatment, total clinical effective rate of observation group was higher than that of control group (P<0.05). Compared with those before treatment, peak expiratory flow (PEF), forced expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FVC) ratio and FEV1 to predicted value ratio (FEV1% pred) in the two groups after treatment were increased (P<0.05), and those indicators in observation group were higher than those in control group (P<0.05). Compared with those before treatment, mMRC score, CAT score, procalcitonin (PCT), C-reactive protein (CRP), interleukine (IL)-18, and tumor necrosis factor (TNF)-α levels in the two groups after treatment were decreased (P<0.05), and those indicators in observation group were lower than those in control group (P<0.05).Conclusion: Xiaochaihu Decoction combined with Guizhi Fuling Pill effectively improved the clinical symptoms and lung function of patients, and smoothly regulate the levels of inflammatory factors in patients with AECOPD.

Downloads

Published

2023-10-09

Data Availability Statement

The data presented in this study are availability on request from the corresponding author.

Issue

Section

Original Research

Similar Articles

1-10 of 83

You may also start an advanced similarity search for this article.